Archives in Chemical Research Open Access

  • ISSN: 2572-4657
  • Journal h-index: 5
  • Journal CiteScore: 1.16
  • Journal Impact Factor: 1.45
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +32 25889658

Perspective - (2023) Volume 7, Issue 2

Azithromycin: A Versatile Antibiotic with Wide Ranging Medical Applications
Nicholas Cullen*
Department of Chemistry, McGill University, Canada
*Correspondence: Nicholas Cullen, Department of Chemistry, McGill University, Canada, Email:

Received: 31-May-2023, Manuscript No. IPACRH-23-17089; Editor assigned: 02-Jun-2023, Pre QC No. IPACRH-23-17089 (PQ); Reviewed: 16-Jun-2023, QC No. IPACRH-23-17089; Revised: 21-Jun-2023, Manuscript No. IPACRH-23-17089 (R); Published: 28-Jun-2023, DOI: 10.21767/2572-4657.7.2.12


Azithromycin, a member of the macrolide antibiotic family, has emerged as a powerful and versatile drug in the field of medicine. Since its introduction in the 1980s, azithromycin has gained popularity due to its unique pharmacokinetic properties, broad-spectrum activity against various pathogens, and relatively mild side effects. In this article, we explore the history, mechanism of action, medical uses, and future prospects of azithromycin. Azithromycin was first discovered in the 1980s by researchers at Pfizer, and it was subsequently approved for medical use in the early 1990s. It belongs to the class of macrolide antibiotics, which are derived from Streptomyces bacteria and are known for their ability to inhibit bacterial protein synthesis. Unlike some other antibiotics, azithromycin is primarily administered orally, making it more convenient for patients.


Azithromycin exerts its antibacterial effects by binding to the ribosomal subunit of bacteria, inhibiting the translocation step of protein synthesis. This prevents the formation of essential proteins necessary for bacterial growth and replication, leading to bacterial cell death. The drug’s unique mode of action contributes to its effectiveness against a broad range of Gram-positive and Gram-negative bacteria, as well as atypical pathogens. Azithromycin is indicated for the treatment of various bacterial infections, including respiratory tract infections, skin and soft tissue infections, sexually transmitted infections (such as chlamydia and gonorrhea), and certain gastrointestinal infections. It is also used as prophylaxis for certain opportunistic infections in immunocompromised individuals. The drug’s extended half-life allows for shorter treatment courses, making it a preferred choice for many infections. Azithromycin has become a frontline treatment for respiratory infections, such as community- acquired pneumonia and acute exacerbations of chronic obstructive pulmonary disease. Its anti-inflammatory properties, in addition to its antibacterial effects, make it beneficial in managing respiratory conditions characterized by excessive inflammation.

As with any antibiotic, the emergence of resistance is a concern. Although azithromycin has shown lower resistance rates compared to other antibiotics, it remains essential to use the drug judiciously to preserve its effectiveness. Continuous surveillance of antibiotic resistance and antimicrobial stewardship are crucial in tackling this issue. Azithromycin is generally well-tolerated, and most side effects are mild and transient. Common side effects include gastrointestinal symptoms, such as nausea and diarrhea, as well as transient changes in liver function tests. It is important for healthcare providers to consider potential drug interactions and contraindications before prescribing azithromycin to individual patients. With the growing challenges of antimicrobial resistance, the future of azithromycin lies in combination therapies and strategic use in infectious disease management. Researchers are exploring novel formulations and delivery methods to enhance the drug’s efficacy while minimizing resistance development. Additionally, ongoing research may uncover new therapeutic uses beyond its current indications.


Azithromycin has established itself as a versatile and valuable antibiotic in the medical arsenal from respiratory infections to sexually transmitted diseases, azithromycin continues to play a crucial role in improving patient outcomes worldwide. As research advances and our understanding of infectious diseases evolves, azithromycin’s future remains bright, offering potential solutions to emerging health challenges while reinforcing its position as a cornerstone in modern medicine.

Citation: Cullen N (2023) Azithromycin: A Versatile Antibiotic with Wide Ranging Medical Applications. Arch Chem Res. 7:12.

Copyright: © 2023 Cullen N. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Awards Nomination 0.329+ Million Readerbase
Share This Page
Recommended Webinars & Conferences